A Clinical Study on the Efficacy of Virechana followed by Bruhat Panchamoola Kashaya in the Management of impaired cholesterol levels

An Open Label Randomised Controlled Clinical Study to Evaluate the Efficacy of Virechana followed by Bruhat Panchamoola Kashaya in the Management of Dyslipidemia - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082027

Enrollment

Registered

2025-03-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Serum CHOLESTEROL (201-400mg/dL) Serum TRIGLYCERIDES (150-400mg/dL) Serum LDL (130-189mg/dL) Serum HDL (1-40mg/dL) Serum VLDL (31-100mg/dL)

Exclusion criteria

Exclusion criteria: Subjects with uncontrolled Diabetes Mellitus with HbA1c more than 10 per cent, IDDM or Hypertension with SBP/DBP more than or equal to 160/110mmHg Subjects with any other known systemic disorder which may interfere with the study Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Virechana followed by Bruhat Panchamoola Kashaya in the management of DyslipidemiaTimepoint: 0th day 71st day	—

Secondary

Measure	Time frame
Lipid profile testTimepoint: Before treatment - 0th day After Virechana - 14th to 16th day After treatment - 59th to 71st day	—

Countries

India

Contacts

Public ContactDr Rajesh A Udapudi

JSS Ayurveda Medical College and Hospital, Mysuru

drrajeshudapudi@gmail.com9844136277

Outcome results